
    
      This open-label clinical trial will compare outcomes of subjects with chronic stroke. Six
      subjects will be to treatment (n=3) groups. The treatment group will receive brain
      transplants of autologous ADSCs. Treatment group will receive rehabilitation after the
      transplantation. Subjects will be assessed by magnetic resonance imaging (MRI) and eight
      standardized stroke indices: National Institutes of Health Stroke Scale (NIHSS), ( Barthel
      Index )、 ( Berg balance scale )、 (Fugl - Meyer test )、(Action research arm test )、 (Purdue
      pegboard )、 ( grip strength measurement ) 、(somatosensory evoked potential, SSEP) at 1 month,
      3 months, and 6 months after treatment.
    
  